Cart
sales@molnova.com
VP3.15 dihydrobromide
CAS No. 1281681-33-1
VP3.15 dihydrobromide( —— )
Catalog No. M20527 CAS No. 1281681-33-1
VP3.15 dihydrobromide is a potent orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1.59 μM 0.88 μMrespectively.)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 5MG | 36 | In Stock |
|
| 10MG | 55 | In Stock |
|
| 25MG | 130 | In Stock |
|
| 50MG | 221 | In Stock |
|
| 100MG | 328 | In Stock |
|
| 200MG | 458 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVP3.15 dihydrobromide
-
NoteResearch use only, not for human use.
-
Brief DescriptionVP3.15 dihydrobromide is a potent orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1.59 μM 0.88 μMrespectively.)
-
DescriptionVP3.15 dihydrobromide is a potent orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1.59 μM 0.88 μMrespectively.)
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3|PDE7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1281681-33-1
-
Formula Weight528.3
-
Molecular FormulaC20H24Br2N4OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (118.30 mM)
-
SMILESBr.Br.C(CN1CCOCC1)N=c1nc(-c2ccccc2)n(s1)-c1ccccc1
-
Chemical Name(23-Diphenyl-2H-[124]thiadiazol-5-ylidene)-(2-morpholin-4-yl-ethyl)-amine Dihydrobromide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Medina-Rodríguez Eva María Bribián Ana Boyd A et al. Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis[J]. Scientific Reports 2017 7:43545.
molnova catalog
related products
-
4-Chloro-2-bromoacet...
4-Chloro-2'-bromoacetophenone against glycogen synthase kinase-3 (GSK-3beta).
-
GSK3-IN-2
GSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.
-
CP21R7
A high-affinity, selective GSK3β inhibitor that activates canonical Wnt signaling.
